176 related articles for article (PubMed ID: 28102191)
21. Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus.
Yamayoshi S; Yasuhara A; Ito M; Uraki R; Kawaoka Y
J Clin Virol; 2018 Nov; 108():105-111. PubMed ID: 30292135
[TBL] [Abstract][Full Text] [Related]
22. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
[TBL] [Abstract][Full Text] [Related]
23. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
[TBL] [Abstract][Full Text] [Related]
24. Generation and characterization of new monoclonal antibodies against swine origin 2009 influenza A (H1N1) virus and evaluation of their prophylactic and therapeutic efficacy in a mouse model.
Wang SF; Tseng SP; Loh EW; Wang WH; Li MC; Chen KH; Tsai WC; Lee YM; Chen HY; Liu FT; Arthur Chen YM; Huang JC
Dev Comp Immunol; 2017 Feb; 67():8-17. PubMed ID: 27984103
[TBL] [Abstract][Full Text] [Related]
25. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the conserved protective epitopes of hemagglutinin on influenza A viruses.
Jiao C; Wang B; Chen P; Jiang Y; Liu J
Front Immunol; 2023; 14():1086297. PubMed ID: 36875062
[TBL] [Abstract][Full Text] [Related]
27. Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V
Lang S; Xie J; Zhu X; Wu NC; Lerner RA; Wilson IA
Cell Rep; 2017 Sep; 20(12):2935-2943. PubMed ID: 28930686
[TBL] [Abstract][Full Text] [Related]
28. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
Wang TT; Tan GS; Hai R; Pica N; Petersen E; Moran TM; Palese P
PLoS Pathog; 2010 Feb; 6(2):e1000796. PubMed ID: 20195520
[TBL] [Abstract][Full Text] [Related]
29. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
Mullarkey CE; Bailey MJ; Golubeva DA; Tan GS; Nachbagauer R; He W; Novakowski KE; Bowdish DM; Miller MS; Palese P
mBio; 2016 Oct; 7(5):. PubMed ID: 27703076
[TBL] [Abstract][Full Text] [Related]
30. Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human.
Yamayoshi S; Ito M; Uraki R; Sasaki T; Ikuta K; Kawaoka Y
J Infect; 2018 Feb; 76(2):177-185. PubMed ID: 29248585
[TBL] [Abstract][Full Text] [Related]
31. An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection.
Zanin M; Keck ZY; Rainey GJ; Lam CY; Boon AC; Rubrum A; Darnell D; Wong SS; Griffin Y; Xia J; Webster RG; Webby R; Johnson S; Foung S
J Virol; 2015 Apr; 89(8):4549-61. PubMed ID: 25673719
[TBL] [Abstract][Full Text] [Related]
32. Neutralizing Antibodies Induced by Gene-Based Hydrodynamic Injection Have a Therapeutic Effect in Lethal Influenza Infection.
Yamazaki T; Nagashima M; Ninomiya D; Ainai A; Fujimoto A; Ichimonji I; Takagi H; Morita N; Murotani K; Hasegawa H; Chiba J; Akashi-Takamura S
Front Immunol; 2018; 9():47. PubMed ID: 29416543
[TBL] [Abstract][Full Text] [Related]
33. Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.
Stadlbauer D; Amanat F; Strohmeier S; Nachbagauer R; Krammer F
Emerg Microbes Infect; 2018 Jun; 7(1):110. PubMed ID: 29925896
[TBL] [Abstract][Full Text] [Related]
34. Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009).
Cabral TM; Berhane Y; Schmidt L; Tracz DM; Hole K; Leith M; Corbett CR
J Virol Methods; 2012 Jul; 183(1):25-33. PubMed ID: 22575685
[TBL] [Abstract][Full Text] [Related]
35. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
Tan Y; Ng Q; Jia Q; Kwang J; He F
J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
Prabhu N; Prabakaran M; Hongliang Q; He F; Ho HT; Qiang J; Goutama M; Lim AP; Hanson BJ; Kwang J
Antivir Ther; 2009; 14(7):911-21. PubMed ID: 19918095
[TBL] [Abstract][Full Text] [Related]
37. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
Williams JA; Gui L; Hom N; Mileant A; Lee KK
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
[TBL] [Abstract][Full Text] [Related]
38. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.
Wilson JR; Guo Z; Reber A; Kamal RP; Music N; Gansebom S; Bai Y; Levine M; Carney P; Tzeng WP; Stevens J; York IA
Antiviral Res; 2016 Nov; 135():48-55. PubMed ID: 27713074
[TBL] [Abstract][Full Text] [Related]
39. Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice.
van der Lubbe JEM; Verspuij JWA; Huizingh J; Schmit-Tillemans SPR; Tolboom JTBM; Dekking LEHA; Kwaks T; Brandenburg B; Meijberg W; Zahn RC; Roozendaal R; Kuipers H
Front Immunol; 2018; 9():2350. PubMed ID: 30369928
[TBL] [Abstract][Full Text] [Related]
40. The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses.
Paules CI; Lakdawala S; McAuliffe JM; Paskel M; Vogel L; Kallewaard NL; Zhu Q; Subbarao K
J Infect Dis; 2017 Aug; 216(3):356-365. PubMed ID: 28633457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
